Maple Leaf Green World Inc. (“Maple Leaf”, “MGW,” or the “Company”) (NEO:MGW) (OTCQX:MGWFF) is pleased to announce the cultivation and extraction teams for the Company’s proposed cannabis cultivation facilities in Telkwa, British Columbia (the “Telkwa Facility”) and in Henderson, Nevada (the “Henderson Facility”).

The team, led by Kenneth Suydam, brings over 25 years of combined experience in cultivation and extraction of cannabis to Maple Leaf. Their broad experience and dynamic backgrounds will be crucial to accelerate the Company’s production techniques and will assist the Company in using the most up-to-date cultivation and extraction techniques.

“We are building high-quality cultivation and extraction systems and processes in both our B.C. and Nevada facilities. Today’s exciting announcement means we are poised to accelerate our broad cultivation strategy at MGW,” said Maple Leaf CEO Raymond Lai. “As a very seasoned and highly recommended cultivator and manager, Ken Suydam is playing a critical role in building MGW’s capacity to cultivate and produce some of the highest quality cannabis and cannabis products in the world.”

Details of the cultivation and extraction team are as follows:

Kenneth Suydam, Head of Cultivation & Cannabis Technologies, will oversee all cultivation and extraction activities for MGW.  Kenneth Suydam is a decorated grower; his achievements include but are not limited to:

  • Second place Hybrid at the 2014 High Times Cannabis Cup
  • Second place Indica at the 2014 High Times Cannabis Cup
  • First Place Rosin at the Chalice Awards in 2015 for his work with Essential Extracts — the first-ever rosin (a solventless shatter) award given out in the world

Spenser Sydney, Cultivation Operations Manager, is an award-winning cultivator and extractor with vast experience in Colorado’s growing cannabis market. His accolades include:

  • First place overall at the 2014 Secret Cup in Colorado
  • Best Shatter in the 2015 High Times U.S. Cannabis Cup
  • First place CBD at the 2015 High Times U.S. Cannabis Cup for a product he both grew and extracted

Josh Zirlin, Head of Extraction & Product Development, is a top extraction engineer from Colorado. Josh Zirlin specializes in quality control and the effective management of extraction facility build outs, process and procedure development, as well as day-to-day operations management. His awards include:

  • First Place Best Medical Concentrate, Second Place Best U.S. Hash, at the 2014 High Times U.S. Cannabis Cup
  • “Extract Artist of the Year” at the 2014 Cannabis Business Awards
  • First Place Best Concentrate at the 2016 High Times U.S. Cannabis Cup
  • First Place Solvent Extract at the 2017 Barcelona Spannabis

Denis Street Jr., Cultivation Operations Manager, brings a true passion for cannabis cultivation to MGW and decades of hands-on expertise. His valuable background and knowledge help produce high yields, award-winning flowers, top-notch plant nutrition, effective life cycles, unique genealogy, effective pest and disease identification and control, as well as cultivation management. His awards include:

  • First place Rosin at the 2015 Chalice Cup for his work with Dystinctively Different Herb Company (DDHC) with the TheMileHighMan
  • First place for People’s Choice Flower (Purple Dragon) at the 2015 Connoisseur Cup

“The entire team is passionate and deeply committed to producing the best possible plants and products. They are focused and already working as a team to improve all of the cultivation strategies and operations for both of our facilities,” said Maple Leaf’s VP of Business Development, Jameson Welbourn. “Having such a strong team with decades of modern cultivation and extraction experience is a key to achieving our goal of producing the highest quality cannabis and cannabis products in the world.”

“I have confidence and faith in Ken, Josh, Spenser and Denis to expand, innovate and thrive in this fast-growing industry,” he continued. “They are all equally involved in every single part of our cultivation process.”

About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates cannabis projects in British Columbia and Nevada. With over ten years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free, top-quality cannabis products. Maple Leaf’s long-term objective is to produce cannabis oil and to export its products to approved countries. The Company’s common shares are listed for trading on the NEO Exchange under the symbol “MGW” and on the OTCQX market under the symbol “MGWFF”.

For further information, please contact:

Victoria Bostic
Investor Relations
Maple Leaf Green World Inc.
+1(604) 849-4500

Cautionary Statements

This press release includes certain statements and information that may be deemed “forward-looking statements” within the meaning of applicable Canadian securities legislation. Such forward-looking information relates to future events about Maple Leaf’s intended business plans and operations, including the construction and capabilities of the Telkwa Facility and the Henderson Facility, as well as the employees of the Company to be located in both the Telkwa Facility and the Henderson Facility. All information other than historical fact may constitute forward-looking information within the meaning of applicable Canadian securities legislation.

Generally, forward-looking information can be identified by the forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget” or “budgeted”, “scheduled”, “estimates”, “projects”, “intends”, “proposes”, “complete”, “anticipates”, or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: risks related to the development and operation of the Company’s projects, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments involving medical and recreational cannabis, inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms, the medical and recreational cannabis industry in Canada and the United States of America and the jurisdictions where the Company operates generally, income and sales tax and regulatory matters, competition, crop failure, currency and interest rate fluctuations, regulatory approvals including approvals from municipal, provincial, county, state, and federal regulatory bodies in Canada and the United States of America. Although the Company has attempted to identify important factors that could cause results to differ materially from those contained in forward-looking information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed, planned, or intended. Accordingly, such list of factors are not exhaustive. Additional information on these and other factors which could affect the Company’s operations and financial results are discussed in the sections relating to risk factors of the business filed in the Company’s required securities filings with applicable securities commissions or other securities regulatory authorities and which may be accessed through the SEDAR website (

Specifically, this press release includes, but is not limited to, forward-looking information with respect to the construction and staff of both the Telkwa Facility and the Henderson Facility. Forward-looking information necessarily involves both known and unknown risks and uncertainties that could cause actual result to differ materially from those anticipated.

Although, the Company believes that expectations and assumptions reflected in the forward-looking information are reasonable, there can be no assurance that any forward-looking information will prove accurate, and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. These forward-looking statements are made as of the date of this press release and the Company does not undertake to update any forward-looking information contained in this press release or that is incorporated by reference herein, whether as a result of new information, future events or results or otherwise, except in accordance with applicable securities laws.

Click here to connect with Maple Leaf Green World Inc. (NEO:MGW) (OTCQX:MGWFF) for an Investor Presentation. 


Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less